We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Safety Labeling on Endologix AFX Endovascular Graft Systems
FDA Updates Safety Labeling on Endologix AFX Endovascular Graft Systems
The FDA has approved new safety labeling for Endologix’s AFX2 endovascular graft systems, which is used to treat patients with abdominal aortic aneurysm (AAA).